期刊文献+

酶联荧光分析法测定血清心肌肌钙蛋白I 被引量:1

Determination of cardiac troponin I in serum by enzyme-linked fluorescent assay
下载PDF
导出
摘要 目的对酶联荧光分析法(ELFA)检测血清心肌肌钙蛋白I(cTnI)进行方法学评价,并探讨其临床应用价值。方法系统研究ELFA法测定cTnI的精密度、灵敏度、线性范围、回收率、标准曲线的稳定性及干扰因素,并与酶联免疫吸附试验(ELISA)检测结果相比较。同时应用ELFA法测定50名正常人、62例非心肌梗死患者及53例急性心肌梗死(AMI)患者的血清cTnI水平。结果ELFA法检测cTnI的总CV值为2.58%~4.82%,分析灵敏度为0.05μg/L,线性范围0.1~50μg/L,稀释标本的平均回收率为101.2%,标准曲线至少可稳定14d。ELFA法(Y)与ELISA法(X)具有良好的相关性(Y=0.983X-0.148,r=0.996)。加入高浓度的胆红素、三酰甘油和血红蛋白对测定无显著性影响(P>0.05)。AMI患者血清cTnI[(18.6±4.8)μg/L]显著高于正常人[(0.068±0.014)μg/L]和非心肌梗死患者[(0.055±0.021)μg/L](P<0.01);cTnI诊断AMI的阈值为0.8μg/L,诊断敏感度、特异度、准确度分别为91.4%、93.8%、92.9%,阳性和阴性拟然比分别为14.6和0.09。结论ELFA法操作简便、结果准确可靠、自动化程度高,且检测快速,具有较高的精密度;cTnI是敏感、特异的心肌标志蛋白,适合在临床工作中推广应用。 Objective To evaluate the analytical features of the new automated cardiac troponin I(cTnI) assay using enzyme-linked fluorescent assay(ELFA) technology and to obtain information about its utility in clinical studies. Methods The parameters links precision,analytical sensitivity,linearity range,recovery rate,calibration curve stability and interfere factors of the cTnI assay were determined. The comparison study was also performed versus enzyme-linked immunosorbent assay(ELISA). cTnI concentration was determined in 50 healthy individuals,62 patients without acute myocardial infarction(AMI) and 53 patients with AMI by ELFA. Results The total coefficient of variation was from 2.58 % to 4.82%. The minimal detection limit was 0.05μg/L. The linearity range was from 0.1 μg/L to 50μg/L. The mean recovery rate of dilution samples was 101.2%. The calibration curve was stable for at least fourteen days. Linear regression analysis showed a good correlation between the ELFA(Y) and ELISA(X) methods(Y=0.983X-0.148,r=0.996). Adding of high concentration of bilirubin,triglyceride or hemoglobin into samples did not interfere cTnI measurement by proposed method(P>0.05). The statistical difference was much higher in patients with AMI compared with healthy individuals[(18.6±4.8)μg/L vs (0.068±0.014)μg/L,P<0.01] or without AMI[(18.6±4.8)μg/L vs ( 0.055 ±0.021)μg/L,P<0.01]. The cutoff value was 0.8μg/L for laboratory diagnosis of AMI,and sensitivity,specificity,accuracy,positive likelihood ratio and negative likelihood ratio were 91.4%, 93.8 %,92.9%,14.6 and 0.09,respectively. Conclusion The ELFA method is reliable,precise,fairly rapid and easy to perform. cTnI is a sensitive and specific marker of myocardial damage. This method is very useful and suitable for routine determinations of serum cTnI levels in clinical laboratory.
作者 王忠诚
出处 《国外医学(临床生物化学与检验学分册)》 2005年第7期398-400,403,共4页 Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
关键词 酶联荧光分析法 肌钙蛋白I 心肌梗死 酶联免疫吸附试验 Enzyme-linked fluorescent assay Troponin I Myocardial infarction
  • 相关文献

参考文献8

  • 1Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable an-gina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).J Am Coll Cardiol, 2002, 40(7): 1366-1374.
  • 2Schulz O, Kromer A. Cardiac troponin Ⅰ: a potential marker of exercise intolerance in patients with moderate heart failure. Am Heart J, 2002, 144(2): 351-358.
  • 3王忠诚,沈钧乐,王强,府伟灵.心肌肌钙蛋白I的检测方法及临床应用进展[J].国外医学(临床生物化学与检验学分册),2004,25(4):303-305. 被引量:28
  • 4The National Committee for Clinical Laboratory Standards.Evaluation of precision performance of clinical chemistry devices(Second Edition); Tenative Guideline. NCCLS document EP5-T2. PA: NCCLS, 1992.
  • 5The National Committee for Clinical Laboratory Standards.Method comparison and bias estimation using patient samples; Approved Guideline. NCCLS document EP9-A. PA:NCCLS, 1995.
  • 6何秉贤.急性冠状动脉综合征心肌标志物检测的现状[J].中华心血管病杂志,2003,31(1):67-68. 被引量:42
  • 7林果为 沈福民.现代流行病学--临床疾病诊断研究及其评价[M].上海:上海医科大学出版社,2001.42-66.
  • 8Christenson RH, Azzazy HM. Biochemical markers of the acute coronary syndromes. Clin Chem, 1998, 44(8 Pt 2):1855-1864.

二级参考文献13

  • 1Apple FS,Wu AH,Jaffe AS,et al.European society of cardiology and American college of cardiology guidelines for redefinition of myocardial infarction:how to use existing assays clinically and for clinical trials.Am Heart J,2002,144(6):981-986.
  • 2Eugene B,Raymond J,Elliott M,et al.ACC/AHA 2002 guidline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction.J Am Coll Cardiol,2002,40(7):1366-1374.
  • 3Giraldi F,Grazi S,Guazzi MD.Valutazione prococe del risultato della trombolisi sistermica nell'infar to miocardico acuto:Valore della troponin I.Cardiologia,1998,43(5):485-491.
  • 4La-Vecchia L,Mezzena G,Ometto R,et al.Detectable serum troponin I in patients with heart failure of nonmyocardial chemic origin.Am J Cardiol,1997,80(1):88-90.
  • 5Galvani M,Ottari F,Ferrini D,et al.Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina.Circulation,1997,95(8):2053-2059.
  • 6Adams JE,Sicard GA,Allen BT,et al.Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I.N Engl J Med,1994,330(10):670-674.
  • 7Apple FS.Clinical and analytical standardization issues confronting cardiac troponin I.Clin Chem,1999,45(1):18-20.
  • 8Schulz O,Kromer A.Cardiac troponin I:a potential maker of exercise intolerance in patients with moderate heart failure.Am Heart J,2002,144(2):351-358.
  • 9Panteghini M.Present issues in the determination of troponins and other markers of cardiac damage.Clin Biochem,2000,33(3):161-166.
  • 10Christenson RH,Apple FS,Morgan DL,et al.Cardiac troponin I measurement with the access immunoassay system.Clin Chem,1998,44(1):52-60.

共引文献68

同被引文献19

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部